April 2026

1905 articles
Nova Minerals has sent out its Scheme Booklet to shareholders and warrantholders, setting the stage for a May 29 vote on its proposed move from Australia to the US. The Independent Expert backs the scheme, and directors recommend approval.
Maxwell Dee
Maxwell Dee
28 Apr 2026
IDT Australia is poised for its strongest FY26 finish since its transformation began, forecasting a dramatic narrowing of EBITDA losses and revenue growth driven by strategic partnerships and operational upgrades.
Victor Sage
Victor Sage
28 Apr 2026
FIN Resources has delivered standout assay results from the first drillhole at Cabin Lake, revealing a broad, continuous high-grade gold system. The 26.2-metre intersection grading 12 g/t Au underpins the project's potential in Canada’s Northwest Territories.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Tinybeans Group has reported its inaugural EBITDA-positive quarter with US$8K profit, driven by strong subscription growth, e-commerce expansion, and operational efficiencies following the Qeepsake acquisition.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Acrux pivots from generics to developing a Female Testosterone therapy for HSDD, leveraging FDA feedback and a strong US market opportunity.
Ada Torres
Ada Torres
27 Apr 2026
Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.
Maxwell Dee
Maxwell Dee
27 Apr 2026
HighCom Technology secures a nearly A$10 million contract from the Australian Defence for counter small uncrewed aerial systems, marking its first major C-UAS order and reinforcing its defence sector presence.
Victor Sage
Victor Sage
27 Apr 2026
Atomo Diagnostics capitalises on Lumos Diagnostics’ FebriDx FDA CLIA waiver with over $2 million in new sales orders and a $3 million capital raise, expanding its global footprint and product pipeline.
Ada Torres
Ada Torres
27 Apr 2026
Aurum Resources has boosted its total gold resources to 4.2 million ounces across two Côte d’Ivoire projects, supported by ongoing drilling and a strategic placement led by Perseus Mining. The company’s strong cash position and board strengthening set the stage for upcoming feasibility milestones.
Maxwell Dee
Maxwell Dee
27 Apr 2026
CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.
Ada Torres
Ada Torres
27 Apr 2026
Horseshoe Metals reveals high-grade gold and silver assays that enhance the value of copper Direct Shipping Ore at Horseshoe Lights, unlocking new revenue potential amid strong copper prices and active offtake talks.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Rakon Limited has swung back to profit in FY26, reporting a 24% revenue lift and doubling EBITDA, while Bourns' takeover offer edges closer to completion with 85% shareholder acceptance and pending French regulatory approval.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Oceana Metals is set to transform its portfolio with the acquisition of the Serra Negra rare earths and niobium project in Brazil, backed by a $20 million placement to fund aggressive exploration.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Axtec Limited has sold its PaySure loan book to Real Flow and secured a minority stake in the fintech, marking a strategic shift towards a platform-focused, AI-driven distribution model.
Claire Turing
Claire Turing
27 Apr 2026
IRIS Metals has revealed a 3.03Mt lithium resource at its fully permitted Beecher Project in South Dakota, featuring a notable rubidium component with a high-grade zone containing around 2,100 tonnes of Rb2O. This positions Beecher as a rare multi-commodity critical minerals asset in a top US mining jurisdiction.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Elsight’s Halo connectivity platform has gained critical approval on the U.S. Department of War’s DCMA Blue List, enabling rapid military procurement amid a historic US$75 billion drone budget surge.
Maxwell Dee
Maxwell Dee
27 Apr 2026
First Au Limited has boosted confidence in its Gimlet Gold Project by upgrading 62% of its resource to Indicated, while streamlining its focus on Western Australian gold through the acquisition of the Barlee Project and exiting offshore assets.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Cazaly Resources has delivered promising high-grade gold assay results from its latest drilling at the Goongarrie Gold Project, extending mineralisation depth and strike length while initiating a new gravity survey to refine exploration targets.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Osmond Resources has released final assays from its Phase 1 drilling at the Orión EU Critical Minerals Project in Spain, revealing significant enrichment of titanium, zirconium, and rare earth elements over a 10km strike. The discovery of a new basal mineralised seam adds to the project's scale, with Phase 2 drilling imminent and a Scoping Study targeted for late 2026.
Maxwell Dee
Maxwell Dee
27 Apr 2026
Amplia Therapeutics reported mature ACCENT trial data showing improved survival and multiple complete responses with narmafotinib, alongside a GMP production milestone and CFO appointment.
Ada Torres
Ada Torres
27 Apr 2026
FortifAI’s Nol8 FPGA appliance dramatically reduces AI infrastructure costs by replacing up to 60,000 CPUs, slashing annual operational expenses from millions to tens of thousands of dollars.
Sophie Babbage
Sophie Babbage
27 Apr 2026
Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.
Ada Torres
Ada Torres
27 Apr 2026
Xamble Group stabilised revenue at A$1.64 million in Q1 2026 while narrowing its group EBITDA loss slightly despite ramped-up technology spending. The company completed its acquisition of YouthsToday, tripling its influencer base and locking in three commercial contracts worth A$1.17 million.
Sophie Babbage
Sophie Babbage
27 Apr 2026
OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.
Ada Torres
Ada Torres
27 Apr 2026